PCRX · ISSUER CIK 1396814
Pacira BioSciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Pacira BioSciences, Inc. insiders reported $0.00 of open-market purchases and $289K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$289KInsider selling
−$289KNet open-market
Oct 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 202619:07 | Oct 8, 2026 | PCRX | Senior Vice President, Finance | S · Sell10b5-1 | $36.32 | −6,000 | 62,284 | -9% | −$218K | ||
| Oct 9, 202619:07 | Oct 8, 2026 | PCRX | Senior Vice President, Finance | M · Exercise10b5-1 | $32.35 | +6,000 | 68,284 | +10% | $194K | ||
| Aug 18, 202617:21 | Aug 17, 2026 | PCRX | Chief Medical Officer | S · Sell10b5-1 | $23.23 | −3,040 | 216,384 | -1% | −$71K |